Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
SAN DIEGO, Nov. 9, 2012 /PRNewswire/ -- The CEO of Verum.de  (Verum), a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif. will speak at an upcoming event held by BIOCOM , the large regional life science association, on Tuesday, Nov. 13, 2012 at 7:30 a.m. PST. The session, Legal and Regulatory Update - Health Care Reform and FDA Developments, will feature Verum CEO Christian Sacher presenting about the clinical trial approval process in the European Union and the proposed changes to the EU trial regulations.
Verum joined BIOCOM earlier this year to expand awareness of its flexible and responsive services  and its ability to run clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. With more than 25 years experience running clinical trials in Eastern Europe, Sacher is considered a pioneer in the industry. He helped bring ethical committees and Western best practices to trials in the region.
"It is an honor to have the opportunity to speak at BIOCOM as the organization mirrors Verum's values regarding clinical trials," says Christian Sacher. "With both FDA and European regulations constantly changing, we need to help biotech, pharma and device companies stay on top of the latest developments."
Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials. The new office  is headed by Kristi Clark, an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.
German-based Verum.de was